Mechanistic analysis of endothelial lipase G promotion of the occurrence and development of cervical carcinoma by activating the phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B/mechanistic target of rapamycin kinase signalling pathway
Lipase G, endothelial type (LIPG) is expressed abundantly in tissues with a high metabolic rate and vascularisation. Research on LIPG has focussed on metabolic syndromes. However, the role of LIPG in providing lipid precursors suggests that it might function in the metabolism of carcinoma cells. Ana...
Main Authors: | Jing Huang, Renci Liu, Yiwen Zhang, Xiujie Sheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Journal of Obstetrics and Gynaecology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/01443615.2022.2151353 |
Similar Items
-
Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
by: Kasun Wanigasooriya, et al.
Published: (2020-05-01) -
The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology
by: James A. McCubrey, et al.
Published: (2010-08-01) -
Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors
by: Qin Xia, et al.
Published: (2020-10-01) -
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance
by: Naji Kharouf, et al.
Published: (2024-01-01) -
Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
by: Wennan Zhao, et al.
Published: (2017-01-01)